Expression of receptor activator of nuclear factor κβ ligand (RANKL) and tumour necrosis factor related, apoptosis inducing ligand (TRAIL) in breast cancer, and their relations with osteoprotegerin, oestrogen receptor, and clinicopathological variables

BACKGROUND: Receptor activator of nuclear factor κβ ligand (RANKL) has an important role in bone remodelling, and tumour necrosis factor related, apoptosis inducing ligand (TRAIL) can induce apoptosis in cancer cells. Their functions are linked by their interactions with osteoprotegerin (OPG). OBJEC...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Cross, S S, Harrison, R F, Balasubramanian, S P, Lippitt, J M, Evans, C A, Reed, M W R, Holen, I
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Group 2006
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1860414/
https://ncbi.nlm.nih.gov/pubmed/16489180
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jcp.2005.030031
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados